Literature DB >> 6534151

Perfluorinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygen.

L C Clark, J L Ackerman, S R Thomas, R W Millard, R E Hoffman, R G Pratt, H Ragle-Cole, R A Kinsey, R Janakiraman.   

Abstract

Emulsions of fluorocarbons are finding considerable use in physiology for intravascular oxygen transport. Their wide clinical application as blood substitutes, anti-shock, and anti-ischemic agents seems imminent. Whole body NMR imaging is rapidly gaining clinical application and may one day almost completely supplant X-ray imaging. All of the 19F compounds used in biocompatible fluorocarbon emulsions give 19F signals identical to those in the corresponding neat liquid. In concentrations of 10% w/v they are readily imaged. The paramagnetic oxygen molecule reduces T1 in such a way as to make possible whole body imaging of oxygen. T1 typically decreases from 1-4 to 0.3-0.5 seconds and is an inverse linear function of oxygen tension. Spin-lattice relaxation times versus oxygen tensions from 0 to 600 torr have been obtained for F-decalin, F-tributylamine, and F-44E. The usefulness of these 19F effects in clinical NMR imaging depends upon the sensitivity of the method and the tolerable dose. The 19F signal may find use in monitoring 19F compounds as vapors or gases dissolved in plasma or in perfluorocarbons in neat liquid or particle form.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6534151     DOI: 10.1007/978-1-4684-4895-5_81

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

Review 1.  Is there a path beyond BOLD? Molecular imaging of brain function.

Authors:  Alan P Koretsky
Journal:  Neuroimage       Date:  2012-03-03       Impact factor: 6.556

Review 2.  Theory, instrumentation, and applications of electron paramagnetic resonance oximetry.

Authors:  Rizwan Ahmad; Periannan Kuppusamy
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Dual-function pH and oxygen phosphonated trityl probe.

Authors:  Andrey A Bobko; Ilirian Dhimitruka; Denis A Komarov; Valery V Khramtsov
Journal:  Anal Chem       Date:  2012-06-27       Impact factor: 6.986

4.  Fluorine (19F) MRS and MRI in biomedicine.

Authors:  Jesús Ruiz-Cabello; Brad P Barnett; Paul A Bottomley; Jeff W M Bulte
Journal:  NMR Biomed       Date:  2010-09-15       Impact factor: 4.044

Review 5.  Prognostic Value of Fluorine-19 MRI Oximetry Monitoring in cancer.

Authors:  Fanny Chapelin; Roberto Gedaly; Zachary Sweeney; Liza J Gossett
Journal:  Mol Imaging Biol       Date:  2021-10-27       Impact factor: 3.488

Review 6.  Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.

Authors:  Raquel Díaz-López; Nicolas Tsapis; Elias Fattal
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

Review 7.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

8.  Synthesis and characterization of amino derivatives of persistent trityl radicals as dual function pH and oxygen paramagnetic probes.

Authors:  Ilirian Dhimitruka; Andrey A Bobko; Christopher M Hadad; Jay L Zweier; Valery V Khramtsov
Journal:  J Am Chem Soc       Date:  2008-07-18       Impact factor: 15.419

9.  Positron Emission Tomography Imaging of Hypoxia.

Authors:  Suzanne E Lapi; Thomas F Voller; Michael J Welch
Journal:  PET Clin       Date:  2009-01-01

10.  Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.

Authors:  Richard Southworth; Megan Kaneda; Junjie Chen; Lei Zhang; Huiying Zhang; Xiaoxia Yang; Reza Razavi; Gregory Lanza; Samuel A Wickline
Journal:  Nanomedicine       Date:  2009-01-19       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.